PuSH - Publication Server of Helmholtz Zentrum München

Journal browsing

19 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
Lay all publications on this page into basket
1.
Walter, J. ; Tufman, A.* ; Holle, R. & Schwarzkopf, L.: Differences in therapy and survival between lung cancer patients treated in hospitals with high and low patient case volume. Health Policy 124, 1217-1225 (2020)
2.
Gansen, F.* ; Severin, F. ; Schleidgen, S.* ; Marckmann, G.* & Rogowski, W.H.: Lethal privacy: Quantifying life years lost if the right to informational self-determination guides genetic screening for Lynch syndrome. Health Policy 123, 1004-1010 (2019)
3.
Becker, C. ; Holle, R. & Stollenwerk, B.: The excess health care costs of KardioPro, an integrated care program for coronary heart disease prevention. Health Policy 119, 778-786 (2015)
4.
Cheung, K.L.* et al.: Understanding the stakeholders' intention to use economic decision-support tools: A cross-sectional study with the tobacco return on investment tool. Health Policy 120, 46-54 (2015)
5.
Rogowski, W.H. & Schleidgen, S.*: Using needs-based frameworks for evaluating new technologies: An application to genetic tests. Health Policy 119, 147-155 (2015)
6.
Severin, F. ; Hess, W.* ; Schmidtke, J.* ; Mühlbacher, A.* & Rogowski, W.H.: Value judgments for priority setting criteria in genetic testing: A discrete choice experiment. Health Policy 119, 164-173 (2015)
8.
Fischer, K.E. ; Rogowski, W.H. ; Leidl, R. & Stollenwerk, B.: Transparency vs. closed-door policy: Do process characteristics have an impact on the outcomes of coverage decisions? A statistical analysis. Health Policy 112, 187-196 (2013)
9.
Vogl, M.: Improving patient-level costing in the English and the German 'DRG' system. Health Policy 109, 290-300 (2013)
10.
11.
Fischer, K.E. ; Leidl, R. & Rogowski, W.H.: A structured tool to analyse coverage decisions: Development and feasibility test in the field of cancer screening and prevention. Health Policy 101, 290-299 (2011)
12.
Hauke, F. & Brückner, U.: First approaches to the monetary impact of environmental health disturbances in Germany. Health Policy 94, 34-44 (2010)
13.
Stock, S.* et al.: Financial incentives in the German Statutory Health Insurance: New findings, new questions. Health Policy 96, 51-56 (2010)
14.
Hartz, S.* & John, J.: Public health policy decisions on medical innovations: What role can early economic evaluation play? Health Policy 89, 184-192 (2009)
15.
Schreyögg, J. ; Bäumler, M.* & Busse, R.*: Balancing adoption and affordability of medical devices in Europe. Health Policy 92, 218-224 (2009)
16.
Gapp, O. ; Schweikert, B. ; Meisinger, C. & Holle, R.: Disease management programmes for patients with coronary heart disease--an empirical study of German programmes. Health Policy 88, 176-185 (2008)
17.
Rogowski, W.H.: Current impact of gene technology on healthcare: A map of economic assessment. Health Policy 80, 340-357 (2007)
18.
LeidI, R.: Training health services managers: Improving health by more health economics? Health Policy 9, 25-37 (1988)
19.